Stem cell injection for interstitial lung disease
Part of Lungs & breathing clinical trials.
This early-phase trial tests if stem cells from donated umbilical cords can help people with interstitial lung disease. It's designed for people whose lung function is moderately reduced and who haven't tried stem cell therapy before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and diagnosed with interstitial lung disease.
- Your recent lung function tests should show your lung capacity and gas exchange are at a moderate level (between 30% and 80% of normal).
- You cannot need oxygen therapy for more than 15 hours a day or have had recent severe lung infections.
- You cannot have had stem cell treatment before, and you must not have had certain cancers in the last 5 years.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether stem cells from fat tissue can help people with connective tissue diseases (like lupus or scleroderma) whose lung scarring has worsened despite standard treatments. It aims to slow or stop lung damage.
This early-stage trial tests a new treatment using extracts from human umbilical cord stem cells, given by inhalation, to see if it is safe and can help patients with interstitial lung disease (a condition where lung tissue becomes scarred and stiff). The study will measure whether this approach reduces symptoms and improves how well your lungs work.
This trial tests a new inhaled treatment made from placental stem cells to see if it's safe and helps slow scarring in the lungs (idiopathic pulmonary fibrosis). The treatment is breathed in through a nebulizer, similar to an asthma inhaler.
This trial is testing a new stem cell therapy made from menstrual blood (SC01009) for people with IPF. It may help reduce lung scarring and improve breathing. Participants must already be on standard IPF treatment.
This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.
This trial tests whether a special type of stem cells from umbilical cords can help people with scleroderma-related lung disease that is getting worse. You may qualify if your lung function has declined despite current treatments.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.